Blindness is one of the most terrible conditions that human beings can experience, since those of us who can see depend on sight for almost all of our daily activities. Therefore, aids for the blind have always been given special consideration. These aids include texts written in Braille, Braille printers, electronic magnifying glasses, mobility aids, books and other texts read aloud, talking watches, and many more. A 2008 article published in Communications of the ACM summarizes the state of these aids at that time. In particular, Chieko Asakawa has been working in the field of mobility aids for the blind for years, having published at least ten articles on the subject between 1998 and 2019.
In a
previous post, I mentioned that the possibility of
designing artificial eyes, which would restore sight to the blind… is one
of the most promising lines of research at present. So promising that these advances are sometimes
announced as immediate. Thus, in December 2011, a forecast published in IEEE
Spectrum for 2012 stated, among other things, the following:
Predict the
next century and you can fantasize; predict the coming decade and you can wax
enthusiastic. But if you’re looking at just the next 12 months, you’d better
keep your feet on the ground. That’s what we’ve done in this year’s tech
survey: In choosing our subjects, we considered mainly the likelihood of their
figuring prominently in the coming year’s tech headlines, not whether we
thought—or hoped—the technologies themselves would succeed. Among the
technologies that we think will be in the news [in 2012] are… electrodes that
will bring eyesight to the blind.
The article associated
with the prediction announced that the first device designed to improve
vision for people with retinitis pigmentosa, and possibly also for those with
macular degeneration, would be marketed in 2012. The author of the article said
this:
The process
that allows the blind to see starts with a pair of sunglasses, which sport a
tiny video camera mounted in the bridge just above the nose. The camera
captures an image and sends it down a wire to a visual processing unit hanging
on the patient’s belt. That VPU—which is a little larger than a smartphone—converts
the world’s complexities into a 60-pixel image in black and white, which it
sends back to transponders on the glasses. From there the image goes
wirelessly to antennas wrapped around the sides of the eyeball, and
from there to the 60-electrode array that is tacked to a delicate retina.
In fact, the prediction was tricky, because the
company Second Sight had put on sale in Europe the device in question (the Argus
retinal prosthesis) in 2011, and what the magazine was actually
predicting was its approval in the United States, which did not happen until
early 2013, a couple of months later than IEEE Spectrum’s prediction.
When the Second Sight company went bankrupt in 2020, its blind users were left without support. As a follow-up to its 2011 article, IEEE Spectrum published a new one in 2023, analyzing possible solutions, which would involve the entry in the field of other companies.
But important news broke a few days ago,
on October 20, 2025, when The New England Journal of Medicine published an article announcing that the authors had successfully developed an ocular implant
that corrects age-related macular degeneration. The news has been reported in
many media outlets, including Physics World and Scientific American. The first article describes it as follows:
A tiny
wireless implant inserted under the retina can restore central vision to
patients with sight loss due to age-related macular degeneration (AMD). In an
international clinical trial, the PRIMA (photovoltaic retina implant
microarray) system restored the ability to read in 27 of 32 participants
followed up after a year.
The solution described consists of two components: the surgical implant in the macular area of a 2x2 millimeter plate, 30 microns
thick, with a total of 378 pixels, and glasses equipped with a camera that
sends the image to the implant using infrared light. The Scientific American
article adds the following disclaimer:
An
electronic retinal implant has improved vision in people with age-related
macular degeneration—but it isn’t a full restoration, and it didn’t improve
participants’ quality of life.
In any case, it’s a very important advance, which
points the way to new inventions. I wouldn’t be surprised if, within a few
decades, it may be possible to restore full sight to the blind. I think it’s a
much more interesting and useful advance, and far more feasible, than the
search for “general artificial intelligence,”
Thematic Thread on Medicine: Previous Next
Manuel Alfonseca
No comments:
Post a Comment